Precision Optics Reports Third Quarter Fiscal Year 2021 Financial Results

GARDNER, Mass., May 13, 2021 /PRNewswire/ — Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced…

GARDNER, Mass., May 13, 2021 /PRNewswire/ — Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its third quarter fiscal year ended March 31, 2021.

Third quarter fiscal 2021 highlights:

  • Revenue for the quarter ended March 31, 2021 was $2.46 million compared to $2.37 million in the same quarter of the previous fiscal year.
  • Gross margins for the quarter ended March 31, 2021 were 33% compared to 34% in the same quarter of the previous fiscal year; and compared to 31% for the quarter ended December 31, 2020.
  • Net Income of $552,280 during the quarter included $809,000 of Other Income due to the forgiveness of the SBA PPP Loan as well as $86,000 of stock-based compensation. This compared to a loss of $466,000, including $76,000 of stock-based compensation in the same quarter of the previous fiscal year.
  • The Company’s cash position remains strong with an ending balance for the third quarter of $782,000.

Precision Optics’ CEO, Joseph Forkey, commented, «The market opportunity for micro-optic and 3D-enabled devices and components in the medical and defense industries continues to be robust. Large, established industry players, and well-funded startup companies are looking for enabling technology partners, such as Precision Optics, that can make next generation products a reality. Over the past couple of years, we have made significant progress expanding the number of jointly developed projects in our engineering pipeline.  We expect many of these to move into production in the coming year to help drive growth.»

Dr. Forkey continued, «While our ongoing production levels continue to be depressed due to the pandemic, the increase in engineering pipeline activity has helped to cushion the impact on overall revenues.  Our production revenue of $1.9 million during the quarter was flat compared to the most recent quarter and was down about $250,000 from the third quarter a year ago. Engineering revenue of $550,000 was down sequentially, but was up year-over-year, and is expected to increase again in future quarters.  Due to revenue recognition timing, reported revenue growth quarter-to-quarter may not reflect the full underlying growth trend of the business.  Further, we have efficiently managed the business with year-to-date improvements in adjusted EBITDA of over $500,000 compared to the same period a year ago. With a burgeoning pipeline, near-term projects expected to move from the pipeline to production, and the resumption of normalized production levels for products impacted by the pandemic, we believe we are well positioned heading into fiscal 2022.»

The following table summarizes the third quarter (unaudited) results for the periods ended March 31, 2021 and 2020:



Three Months



Ended Mar 31,



2021

2020

Revenues

$      2,458,290

$      2,374,584





Gross Profit

818,024

817,019





Stock Compensation Expenses

74,794

64,334

Other

999,248

1,218,132

Total Operating Expenses

1,074,042

1,282,466





Operating Income (Loss)

(256,018)

(465,447)





Net Income (Loss)

552,278

(466,130)





Income (Loss) per Share




Basic

$                0.04

$              (0.04)


Fully Diluted

$                0.04

$              (0.04)





Weighted Average Common Shares

Outstanding




Basic

13,243,595

12,982,494


Fully Diluted

14,068,459

12,982,494

 

Conference Call Details

The Company has scheduled a conference call to discuss the third quarter 2021 financial results for Thursday, May 13, 2021 at 5:00pm ET.

Call-in Information: Interested parties can access the conference call by dialing (844) 735-3662 or

(412) 317-5705.

Live Webcast Information: Interested parties can access the conference call via a live Internet webcast, which is available at https://www.webcaster4.com/Webcast/Page/2109/40924.  

Replay: A teleconference replay of the call will be available until May 20, 2021 at (877) 344-7529 or (412) 317-0088, confirmation # 10155310. A webcast replay will be available at https://www.webcaster4.com/Webcast/Page/2109/40924.  

About Precision Optics Corporation

Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture.  Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Ross Optical division’s high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.

About Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company’s intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company’s future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by the Company’s management. These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in the Company’s annual report on Form 10-K and in other documents that we file from time to time with the SEC. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement, except as required by law.

Company Contact:                                                     

PRECISION OPTICS CORPORATION

22 East Broadway

Gardner, Massachusetts 01440-3338

Telephone: 978-630-1800

Investor Contact:

LYTHAM PARTNERS, LLC

Robert Blum

Phoenix | New York

Telephone: 602-889-9700

peye@lythampartners.com

 

Following are the Company’s Consolidated Balance Sheets at March 31, 2021 and June 30, 2020, and Statements of Operations, for the three and nine month periods ended March 31, 2021 and 2020:

PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)




March 31,

2021



June 30,

2020


ASSETS









Current Assets:









Cash and cash equivalents


$

781,845



$

1,134,697


Accounts receivable (net of allowance for doubtful accounts of $250,633 at

March 31, 2021 and $248,450 at June 30, 2020)



1,533,781




1,481,437


Inventories



1,949,281




2,197,244


Prepaid expenses



132,156




133,707


Total current assets



4,397,063




4,947,085











Fixed Assets:









Machinery and equipment



3,084,691




2,907,533


Leasehold improvements



765,780




731,801


Furniture and fixtures



178,640




178,640





4,029,111




3,817,974


Less—Accumulated depreciation and amortization



3,419,203




3,314,824


Net fixed assets



609,908




503,150











Operating lease right-to-use asset



75,804




118,403


Patents, net



135,536




95,229


Goodwill



687,664




687,664











TOTAL ASSETS


$

5,905,975



$

6,351,531











LIABILITIES AND STOCKHOLDERS’ EQUITY









Current Liabilities:









Current portion of capital lease obligation


$

37,779



$

51,761


Current portion of acquisition earn out liability



166,667




166,667


Note payable to bank






808,962


Accounts payable



1,024,611




1,066,005


Customer advances



232,884




417,059


Accrued compensation and other



585,463




581,770


Current portion of operating lease liability



60,131




57,156


Total current liabilities



2,107,535




3,149,380











Capital lease obligation, net of current portion



162,200




35,810


Acquisition earn out liability



166,666




333,333


Operating lease liability, net of current portion



15,673




61,247











Stockholders’ Equity:









Common stock, $0.01 par value: 50,000,000 shares authorized; issued and

outstanding – 13,263,789 shares at March 31, 2021 and 13,191,789 June 30,

2020



132,638




131,918


Additional paid-in capital



50,044,789




49,702,986


Accumulated deficit



(46,723,526)




(47,063,143)


Total stockholders’ equity



3,453,901




2,771,761











TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY


$

5,905,975



$

6,351,531


 

PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE AND NINE MONTHS ENDED

MARCH 31, 2021 AND 2020

(UNAUDITED)




Three Months

Ended March 31,



Nine Months

Ended March 31,




2021



2020



2021



2020


Revenues


$

2,458,290



$

2,374,584



$

8,001,641



$

7,686,330



















Cost of Goods Sold



1,640,266




1,557,565




5,353,999




4,977,255


Gross Profit



818,024




817,019




2,647,642




2,709,075



















Research and Development Expenses, net



146,063




319,875




443,609




700,605


Selling, General and Administrative Expenses



927,979




962,591




2,671,176




3,111,397


Total Operating Expenses



1,074,042




1,282,466




3,114,785




3,812,002



















Operating Loss



(256,018)




(465,447)




(467,143)




(1,102,927)



















Other Income (Expense)

















Interest Expense



(666)




(683)




(2,202)




(138)


Gain on Forgiveness of Bank Note



808,962







808,962






















Net Income (Loss)


$

552,278



$

(466,130)



$

339,617



$

(1,103,065)



















Income (Loss) Per Share:

















Basic


$

0.04



$

(0.04)



$

0.03



$

(0.09)


Fully Diluted


$

0.04



$

(0.04)



$

0.02



$

(0.09)



















Weighted Average Common Shares Outstanding:

















Basic



13,243,595




12,982,494




13,208,805




12,898,004


Fully Diluted



14,068,459




12,982,494




13,841,700




12,898,004


 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/precision-optics-reports-third-quarter-fiscal-year-2021-financial-results-301291253.html

SOURCE Precision Optics Corporation